Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Transcript, audio, 8-K earnings release, 10-Q stay in one workspace.
Earnings call · FY2026 Q2
Executive readout · one minute
Read the call alongside every captured source. Transcript, audio, 8-K earnings release, 10-Q stay in one workspace.
Management tone
Positive
Net tone +42 · moderate hedging
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
4 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
From the 8-K filed Aug 5, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Capital expenditures
2026
|
$40M – $50M | — |
Listen and read together
The spoken word highlights as audio plays. Select any word to seek to that moment.
much growth could be had there. I think there's a substantial amount of growth. We've had an administration there that hasn't been too favorable to the cannabis operators. I think with a new administration coming in here at the end of the year, there might be an opportunity to expand the medical program with all different sorts of form factors, reciprocity, et cetera. So we'll be working on that diligently because Florida has a massive population, massive tourism population, and I think we could see big growth in the medical market. And fortunately for us, we're ready for We have our third facility ready, willing, and able to open, and we have stores that are coming online, and I believe that there's additional room for growth on the storefront, and we have the cultivation component ready to be able to fill those shelves. So, we're looking forward to a solid 2027 and working with the new incoming administration to make the program bigger and better than it is today.
Thank you. Appreciate that. um second question uh on uh on capital location i guess uh and valuation as well i mean you continue to trade at a because a discount appears despite the um you know the meaningful free cash flow generation that you're seeing and that you expect for the reminder of the year you obviously have the buyback in place and you bought back some stock during the quarter i'm curious how more aggressive could you get on that buyback if this discount persists especially you know as we're close to very significant regulatory reform here with rescheduling. Thank you.
Well, we believe RONO stock is sorely undervalued and it's always an opportunity for us. That being said, we have to weigh all of our opportunities, right? Whether it be M&A, organic growth, investing in our current markets and the buyback. So we're constantly looking at that and we're deploying dollars wherever they make sense to the best of our shareholders, for the best of our shareholders and our company. So we'll continue to get more aggressive there if it makes sense or we'll be investing the dollars somewhere else where we get a better return.
Thank you.
Appreciate that.
Thank you.
Thank you very much. Our next question comes from the line of Neil Gilmer of Haywood Securities. Neil, your line is open.
Yeah, thanks very much and good morning. A lot's been covered here, but maybe talk a little bit more on the wholesale side of things. Obviously, we saw some growth there. It's been a topic of conversation probably over the past sort of five, six quarters with respect to the collections and the AR levels is nice there. So, you know, what are you seeing in the dynamics there? You've obviously got some customers that you're comfortable with. Are you expecting to sort of see that continued growth over the next couple of quarters as sort of just how some of your customers are remaining current in their payables?
Hey, Neil, thanks for the question. Listen, we were probably one of the first to be really aggressive with our wholesale strategy. You know, our AR levels are at the best they've been, and we feel very comfortable with the current base of customers that we have. Obviously, we want to continue to grow that, but we want to grow it at a slow pace where we're comfortable with what we're putting out. And, you know, demand is increasing across the country, so we have to be careful where we're selling our product. We want to make sure we're getting paid for our product and we're not being taken advantage of. So right now we've built a very strong base. Wholesale is back to growth, and we don't see tremendous growth there. We want to be careful about it, but I think we can anticipate some slow growth in wholesale and momentum.
And then maybe a small one here. You tightened up your CapEx guidance range, brought up the lower end of that. Was there any sort of particular projects that you guys decided to move forward with, or is there any sort of CapEx investment required in Virginia given the developments there?
Yeah, you know, we have some additional stores that will be opening at the end of the year. Now that Virginia is final and it's launching July 1st, we just got the second facility approved. We're going to be deploying some additional capital there, as well as some other markets, making some cultivation improvements and opening some additional stores. So we are raising that a bit, and obviously that's for good reason. So we're looking forward to the output from those investments.
Yeah, makes sense. Thanks very much.
Thank you, Neil.
Thank you very much. This concludes the question and answer session. I would now like to turn it back over to George Okos for closing remarks.
Thank you, everyone, for joining us today. Look forward to seeing you next quarter. Enjoy the rest of your summer.
Thank you for your participation in today's conference. This does conclude the program, and you may now disconnect.
SEC filing · Item 2.02
Filed Aug 5, 2026 · complete as-filed document
SEC periodic report
Filed Aug 5, 2026 · complete as-filed document